Eu Ivdd
Eu Ivd General
On The Market
๐ฎ๐ช Ireland
Ristocetin (7.5 mg/vial)
Devices (same UDI-DI)
1
Certificates
0
Countries
10
Notified Bodies
0
Basic Information
- Primary DI
- 05391521420084
- Basic UDI-DI Code
- B-05391521420084
- Reference
- 50705
- Device Types
- None provided
- Regulation
- Eu Ivdd
- Classification
- Eu Ivd General
- Status
- On The Market
- Manufacturer
- Tcoag ireland ltd
Additional Description
Ristocetin is a lyophilized reagent derived from Norcardia lurida which induces platelet aggregation in normal Platelet Rich Plasma (PRP). In von Willebrands disease, Ristocetin-induced platelet aggregation is impaired.
CND Nomenclature Codes
| Code | Description |
|---|---|
| W0103020401 | AGGREGATION REAGENTS |
Available In Countries
๐ฆ๐น Austria
๐ง๐ช Belgium
๐ฉ๐ช Germany
๐ฉ๐ฐ Denmark
๐ช๐ธ Spain
๐ซ๐ฎ Finland
๐ฎ๐น Italy
๐ณ๐ฑ Netherlands
๐ต๐น Portugal
๐ท๐ด Romania
Similar Devices
Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).
BluBox
Device
EU IVDD
·
Eu Ivd General
·Blusense Diagnostics ApS·On the market·5 countries
extendSUREโข HbA1c Liquid Controls
Device
EU IVDD
·
Eu Ivd General
·Canterbury Scientific Limited·On the market·19 countries
ViroTrack Sero COVID-19 Total Ab
Device
EU IVDD
·
Eu Ivd General
·Blusense Diagnostics ApS·On the market·5 countries
extendSURETM Haemoglobin F and A2 Calibrators
Device
EU IVDD
·
Eu Ivd General
·Canterbury Scientific Limited·On the market·8 countries
extendSUREโข Haemoglobin F and A2 Controls
Device
EU IVDD
·
Eu Ivd General
·Canterbury Scientific Limited·On the market·8 countries
extendSUREโข HbA1c Liquid Controls
Device
EU IVDD
·
Eu Ivd General
·Canterbury Scientific Limited·On the market·19 countries